Hospitalized atrial fibrillation after renal transplantation in the United States

American Journal of Transplantation

Volumn 3, Issue 4, 2003, Pages 471-476

  Abbott, Kevin C ^a   Reynolds, Joel C ^a   Taylor, Allen J ^a,b   Agodoa, Lawrence Y ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Atrial fibrillation; Complications; Graft loss; Hospitalization; Hypertension; Obesity; Rejection; United States Renal Data System (USRDS)

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOOD AND DRUG ADMINISTRATION; GRAFT REJECTION; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; REGRESSION ANALYSIS; RISK FACTOR; UNITED STATES;

ATRIAL FIBRILLATION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; RISK FACTORS; UNITED STATES;

EID: 0038666482     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00071.x     Document Type: Article

References (31)

1. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890.
2. Zebe H. Atrial fibrillation in dialysis patients. Nephrol Dial Transplant 2000; 15: 765-768.
3. LoVecchio FA, Goltz HR. Atrial fibrillation following acute overdose with oral cyclosporine. Ann Pharmacother 2000; 34: 405.
4. Zeier M, Dikow R, Ritz E. Blood pressure after renal transplantation. Ann Transplant 2001; 6: 21-24.
5. Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359: 741-746.
6. Abbott KC, Duran M, Hypolite I et al. Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol 2001; 14: 353-360.
7. Tveit DP, Hypolite I, Bucci J et al. Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol 2001; 14: 361-368.
8. Abbott KC, Hypolite IO, Hshieh P et al. Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol 2002; 12: 115-122.
9. Amar D. Postoperative atrial fibrillation. Heart Dis 2002; 4: 117-123.
10. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol 2002; 155: 819-826.
11. Aronow WS. Management of the older person with atrial fibrillation. J Gerontol A Biol Sci Med Sci 2002; 57: M352-M363.
12. Abbott KC, Hypolite IO, Hshieh P, Cruess D, Taylor AJ, Agodoa LY. Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol 2002; 12: 115-122.
13. Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY. Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol 2002; 13: 2560-2569.
14. Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
15. Ko WJ, Lin FL, Wang SS, Chu SH. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. J Heart Lung Transplant 1997; 16: 980-982.
16. Arteaga D, Odor A, Lopez RM et al. Impairment by cyclosporin A of reperfusion-induced arrhythmias. Life Sci 1992; 51: 1127-1134.
17. Zhang W. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. Cardiovasc Res 2002; 53: 294-303.
18. Sakata Y, Masuyama T, Yamamoto K et al. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. Circulation 2000; 102: 2269-2275.
19. Nicolau DP, Uber WE, Crumbley AJ, 3rd, Strange C. Amiodaronecyclosporine interaction in a heart transplant patient. J Heart Lung Transplant 1992; 11: 564-568.
20. Chitwood KK, Abdul-Haqq AJ, Heim-Duthoy KL. Cyclosporineamiodarone interaction. Ann Pharmacother 1993; 27: 569-571.
21. Toraman F, Karabulut EH, Alhan HC, Dagdelen S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 1256-1261.
22. Eray O, Akca S, Pekdemir M, Eray E, Cete Y, Oktay C. Magnesium efficacy in magnesium deficient and nondeficient patients with rapid ventricular response atrial fibrillation. Eur J Emerg Med 2000; 7: 287-290.
23. Guo Y, Hu S, Wu Q, Xu J, Song Y, Zhu X. Predictors of atrial fibrillation after coronary artery bypass graft surgery. Chin Med J (Engl) 2002; 115: 232-234.
24. Trompeter R, Filler G, Webb NJ et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002; 17: 141-149.
25. Levy S. Pharmacologic management of atrial fibrillation: current therapeutic strategies. Am Heart J 2001; 141 (Suppl.): S15-S21.
26. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337: 1667-1674.
27. Cowan DN, DeFraites RF, Gray GC et al. The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med 1997; 336: 1650-1656.
28. Cassel CK, Vladeck BC. ICD-9 code for palliative or terminal care. N Engl J Med 1996; 335: 1232-1234.
29. Ferraresso M, Ghio L, Edefonti A et al. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients. Pediatr Nephrol 2002; 8: 664-667.
30. Morris-Stiff G, Talbot D, Balaji V et al. Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection. Transpl Int 1998; 11 (Suppl. 1): S78-S81.
31. Butani L, Makker SP. Conversion from tacrolimus to neoral for postrenal transplant diabetes. Pediatr Nephrol 2000; 15: 176-178.